Va Researchers Start Clinical Trials On Prostate Cancer Drug Degarelix As Possible Coronavirus Treatment
The drug degarelix, also sold under the brand name Firmagon, was approved as a prostate cancer treatment by the FDA in 2008. It works by acting as a powerful but temporary blocker of testosterone, which is thought to fuel the growth of prostate cancer. The drug is being investigated as a coronavirus treatment because testosterone is also believed to aid in the production of the protein TMPRSS2 in lung tissue, which the virus uses to penetrate lung cells....